Group One Trading’s VolitionRx Ltd VNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5 Sell
20
-2,480
-99% -$1.68K ﹤0.01% 7432
2026
Q2
$3.38K Hold
2,500
– – ﹤0.01% 6881
2026
Q1
$10.1K Hold
2,500
– – ﹤0.01% 6368
2025
Q4
$12.8K Buy
+2,500
New +$19K ﹤0.01% 6668
2022
Q3
– Sell
-8
Closed -$303 – 8315
2022
Q2
$0 Hold
8
– – ﹤0.01% 8588
2022
Q1
$0 Hold
8
– – ﹤0.01% 8781
2021
Q4
$0 Hold
8
– – ﹤0.01% 8896
2021
Q3
$0 Hold
8
– – ﹤0.01% 8846
2021
Q2
$0 Hold
8
– – ﹤0.01% 8608
2021
Q1
$1K Buy
+8
New +$686 ﹤0.01% 7484
2020
Q4
– Sell
-110
Closed -$7K – 7047
2020
Q3
$7K Buy
110
+5
+5% +$340 ﹤0.01% 5549
2020
Q2
$8K Buy
+105
New +$7.58K ﹤0.01% 5234

Other funds holding VNRX

Group One Trading's VNRX Position: Q3 2026 in Review

Group One Trading reduced its VolitionRx Ltd (VNRX) stake by 99% in Q3 2026, selling an estimated $1.68K and leaving 20 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #7432.

Group One Trading first reported a position in VNRX in Q2 2020 and has held it in 12 quarters since. The position peaked at $12.8K in Q4 2025. 14 funds tracked by Wall St. Rank hold VNRX as of Q3 2026.

  • Group One Trading held 20 shares of VolitionRx Ltd worth $5 as of Q3 2026.
  • Group One Trading sold 2,480 VolitionRx Ltd shares in Q3 2026, an estimated $1.68K.
  • VolitionRx Ltd made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7432 holding.
  • Group One Trading first reported a position in VolitionRx Ltd in Q2 2020 and has held it in 12 quarters since.
  • Group One Trading's VolitionRx Ltd position peaked at $12.8K in Q4 2025.
  • 14 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.